We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.14B
AUM Growth
+$47.3M
Cap. Flow
-$93.6M
Cap. Flow %
-8.23%
Top 10 Hldgs %
18.14%
Holding
253
New
32
Increased
64
Reduced
41
Closed
33

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$13.7M
2
HALO icon
Halozyme
HALO
+$10.2M
3
CVCO icon
Cavco Industries
CVCO
+$9.29M
4
MTG icon
MGIC Investment
MTG
+$8.12M
5
RRR icon
Red Rock Resorts
RRR
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Industrials 21.35%
3 Healthcare 13.07%
4 Financials 11.12%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROST icon
151
Ross Stores
ROST
$81.9B
$1.06M 0.09%
6,988
SHOP icon
152
Shopify
SHOP
$195B
$1.02M 0.09%
9,569
BIRK icon
153
Birkenstock
BIRK
$7.07B
$932K 0.08%
16,449
+8,441
+105% +$428K
CVCO icon
154
Cavco Industries
CVCO
$4.55B
$919K 0.08%
2,059
-20,239
-91% -$9.29M
CAVA icon
155
CAVA Group
CAVA
$7.27B
$865K 0.08%
7,670
AXSM icon
156
Axsome Therapeutics
AXSM
$10.9B
$858K 0.08%
10,135
ANET icon
157
Arista Networks
ANET
$238B
$852K 0.07%
+7,710
New +$793K
ORCL icon
158
Oracle
ORCL
$423B
$850K 0.07%
5,100
WTW icon
159
Willis Towers Watson
WTW
$32B
$846K 0.07%
2,700
DKNG icon
160
DraftKings
DKNG
$11.9B
$808K 0.07%
21,710
-2,498
-10% -$99.1K
RGEN icon
161
Repligen
RGEN
$9.25B
$804K 0.07%
5,587
-38,195
-87% -$5.48M
HROW icon
162
Harrow
HROW
$1.51B
$799K 0.07%
23,822
-45,655
-66% -$2.02M
KRYS icon
163
Krystal Biotech
KRYS
$9.66B
$797K 0.07%
5,086
-13,721
-73% -$2.43M
IHI icon
164
iShares US Medical Devices ETF
IHI
$3.37B
$795K 0.07%
+13,629
New +$810K
LRCX icon
165
Lam Research
LRCX
$390B
$779K 0.07%
+10,783
New +$818K
CRMD icon
166
CorMedix
CRMD
$584M
$762K 0.07%
+94,132
New +$940K
BHVN icon
167
Biohaven
BHVN
$2.21B
$697K 0.06%
18,673
-6,776
-27% -$316K
PRAX icon
168
Praxis Precision Medicines
PRAX
$10.1B
$653K 0.06%
+8,481
New +$614K
FLS icon
169
Flowserve
FLS
$10.2B
$623K 0.05%
10,833
XENE icon
170
Xenon Pharmaceuticals
XENE
$6.12B
$575K 0.05%
14,658
HALO icon
171
Halozyme
HALO
$12.2B
$545K 0.05%
11,395
-198,524
-95% -$10.2M
MRVL icon
172
Marvell Technology
MRVL
$196B
$542K 0.05%
+4,906
New +$455K
MELI icon
173
Mercado Libre
MELI
$92.3B
$524K 0.05%
308
CYTK icon
174
Cytokinetics
CYTK
$10.4B
$520K 0.05%
11,049
DPZ icon
175
Domino's
DPZ
$11.6B
$507K 0.04%
1,209
+362
+43% +$158K

Similar funds

Nicholas Investment Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Nicholas Investment Partners held 253 positions worth $1.14B, up 4.3% from $1.09B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $93.6M in Q4 2024, closing 33 positions and reducing 41 holdings. Its most notable exit was Transmedics, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in Rush Street Interactive worth $15M.

  • Nicholas Investment Partners's largest Q4 2024 buy was Rush Street Interactive: 1,091,091 shares worth $15M.
  • Nicholas Investment Partners added most to iShares Russell 2000 ETF in Q4 2024, an estimated $6.59M increase.
  • Nicholas Investment Partners's biggest Q4 2024 reduction was Halozyme, cutting an estimated $10.2M.
  • Nicholas Investment Partners fully exited Transmedics in Q4 2024, selling an estimated $13.7M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.14B portfolio in Q4 2024.
  • Nicholas Investment Partners opened 32 new positions and closed 33 in Q4 2024.
  • Nicholas Investment Partners's portfolio value rose 4.3% quarter-over-quarter to $1.14B.

Based on Nicholas Investment Partners's 13F filing for Q4 2024, filed 14 Feb 2025.